BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

A

Atrogi at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Atrogi takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions cover cardiometabolic medicine beyond GLP-1 and the use of AI in clinical trials. The trials session looks at how AI can transform trial operations and speed up development.

OrganizationBIO-Europe 2026 Attendance
A
Atrogi
Stockholm, Sweden
Biotech
Develops oral small molecules for type 2 diabetes and obesity that increase glucose uptake in skeletal muscle.
Panel
Tue Nov 10
16:00–16:45
AI and Innovation in Clinical Trials: Transforming Operations and Accelerating Development
How AI can speed clinical trials, from drafting trial plans and finding patients to computer-simulated patients that cut how many real ones are needed.
with PharmSky Research, TransPerfect, Biogen
Panel
Tue Nov 10
10:00–10:45
Cardiometabolic innovations beyond GLP-1 – Where are we now?
Which drug approaches beyond GLP-1 medicines are drawing attention for obesity, diabetes and heart disease risk, and where money and partnerships are going.
with LifeArc, IsomAb, V-Bio Ventures +2 more

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Atrogi

Tell us what you sell and we’ll find the people at Atrogi most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction